Differences in COPD: Smokers versus non smokers Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Wood smoke COPD: a new description of a COPD phenotype? Source: Eur Respir J 2014; 44: 261-262 Year: 2014
Wood smoke COPD: a new description of a COPD phenotype? Source: Eur Respir J 2014; 44: 262-263 Year: 2014
Do current smoking COPD patients exacerbate more often? Source: International Congress 2016 – Smoking-related diseases Year: 2016
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Identifying the at risk smokers: who goes on to get COPD? Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019 Year: 2019
Corticosteroids improve lung function and quality of life in subjects with biomass fuel (BMF) smoke exposures induced COPD Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Lung function differences between subjects with tobacco smoke-induced COPD (TS-COPD) and biomass smoke-induced COPD (BS-COPD) in an Indian population Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011
Oral and nasal microbiota in healthy, tobacco smoke COPD (TSCOPD) and biomass smoke COPD (BMSCOPD) subjects from India Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016
Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers) Source: International Congress 2017 – Smoking and health hazards Year: 2017
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
How much do COPD patients smoke? A global survey Source: Annual Congress 2010 - Comorbidities and disease management in primary care Year: 2010
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
COPD hospitalizations in never smokers: comparison with current smokers Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Does knowledge of smokers about chronic obstructive pulmonary disease (COPD) differ than nonsmokers? Source: Eur Respir J 2004; 24: Suppl. 48, 372s Year: 2004
Comparative study of respiratory symptoms, lung function, BMI and exercise capacity in patients with COPD associated with tobacco smoke (TS) and biomass smoke (BS) exposure Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012
COPD patients continue to smoke after being diagnosed for COPD Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020
Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013